Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Acta Biochimica Et Biophysica Sinica|December 20, 2023
Advances in DNA damage response inhibitors in colorectal cancer therapyYue Yu, Hang Jia, Tianshuai Zhang, et al.
Military Medicine|April 23, 2025
Optimizing the Self-Directed Training Kiosk for Tactical Combat Casualty Care Skills Among Chinese Military Service Members: A Kano Model ApproachKaiyue Li, Tianshuai Zhang, Shenjing Yu, et al.
Journal of Nanobiotechnology|January 9, 2022
Nanofiber/hydrogel core-shell scaffolds with three-dimensional multilayer patterned structure for accelerating diabetic wound healingJiankai Li, Tianshuai Zhang, Mingmang Pan, et al.
Frontiers in Immunology|April 20, 2026
Liquid biopsy in cancer drug resistance: real-time monitoring, mechanistic insights, and translational applicationsYiyang Li, Zixuan Liu, Benliang Yuan, et al.
Biofactors (Oxford, England)|March 11, 2025
Spatial and single-cell transcriptomic analysis reveals fibroblasts dependent immune environment in colorectal cancerHang Jia, Xianglin Liu, Guimin Wang, et al.
Frontiers in Immunology|July 15, 2024
Impact and potential value of immunosenescence on solid gastrointestinal tumorsTianshuai Zhang, Rongbo Wen, Hao Fan, et al.
International Journal of Molecular Sciences|March 28, 2026
Baicalin Augments 5-Fluorouracil Efficacy in Colorectal Cancer by Triggering MLKL-Dependent Necroptosis: A Novel Strategy to Overcome ChemoresistanceJingwen Yuan, Zhiying Peng, Rongbo Wen, et al.
Frontiers in Immunology|May 31, 2023
Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatmentRongbo Wen, Leqi Zhou, Zhiying Peng, et al.
BMJ Open|September 14, 2023
Neoadjuvant chemoradiation therapy combined with immunotherapy for microsatellite stable ultra-low rectal cancer (CHOICE II): study protocol of a multicentre prospective randomised clinical trialLeqi Zhou, Guanyu Yu, Rongbo Wen, et al.
International Journal of Surgery (London, England)|May 29, 2025
Tertiary lymphoid structures signature predicts prognosis and clinical benefits from neoadjuvant chemotherapy and PD-1 blockade in colorectal adenocarcinomaZichao Guo, Haoran Feng, Wenqing Jia, et al.
Pageof 2